Physiology and pathophysiology of human airway mucus
The mucus clearance system is the dominant mechanical host defense system of the human
lung. Mucus is cleared from the lung by cilia and airflow, including both two-phase gas-liquid …
lung. Mucus is cleared from the lung by cilia and airflow, including both two-phase gas-liquid …
Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: composition, structure and barrier properties
BC Huck, X Murgia, S Frisch, M Hittinger… - Advanced Drug Delivery …, 2022 - Elsevier
Mucus covers all wet epithelia and acts as a protective barrier. In the airways of the lungs,
the viscoelastic mucus meshwork entraps and clears inhaled materials and efficiently …
the viscoelastic mucus meshwork entraps and clears inhaled materials and efficiently …
Mucins and CFTR: their close relationship
Mucociliary clearance is a critical defense mechanism for the lungs governed by regionally
coordinated epithelial cellular activities, including mucin secretion, cilia beating, and …
coordinated epithelial cellular activities, including mucin secretion, cilia beating, and …
Dornase alfa in Cystic Fibrosis: Indications, comparative studies and effects on lung clearance index
V Terlizzi, C Castellani, G Taccetti, B Ferrari - Italian Journal of Pediatrics, 2022 - Springer
Cystic fibrosis (CF) is the most common inherited disease in Caucasian populations,
affecting around 50,000 patients in Europe and 30,000 in United States. A mutation in CF …
affecting around 50,000 patients in Europe and 30,000 in United States. A mutation in CF …
Viral vectors, animal models, and cellular targets for gene therapy of cystic fibrosis lung disease
Y Tang, Z Yan, JF Engelhardt - Human gene therapy, 2020 - liebertpub.com
After more than two decades since clinical trials tested the first use of recombinant adeno-
associated virus (rAAV) to treat cystic fibrosis (CF) lung disease, gene therapy for this …
associated virus (rAAV) to treat cystic fibrosis (CF) lung disease, gene therapy for this …
Bicarbonate transport of airway surface epithelia in luminally perfused mice bronchioles
L Liu, A Yamamoto, M Yamaguchi, I Taniguchi… - The Journal of …, 2022 - Springer
HCO3− secretion in distal airways is critical for airway mucosal defense. HCO3−/H+
transport across the apical membrane of airway surface epithelial cells was studied by …
transport across the apical membrane of airway surface epithelial cells was studied by …
Inhibition of the sodium-dependent HCO3-transporter SLC4A4, produces a cystic fibrosis-like airway disease phenotype
Bicarbonate secretion is a fundamental process involved in maintaining acid-base
homeostasis. Disruption of bicarbonate entry into airway lumen, as has been observed in …
homeostasis. Disruption of bicarbonate entry into airway lumen, as has been observed in …
Revisiting the mechanism of hypoxic pulmonary vasoconstriction using isolated perfused/ventilated mouse lung
PP Jain, S Hosokawa, M Xiong… - Pulmonary …, 2020 - journals.sagepub.com
Hypoxic Pulmonary Vasoconstriction (HPV) is an important physiological mechanism of the
lungs that matches perfusion to ventilation thus maximizing O2 saturation of the venous …
lungs that matches perfusion to ventilation thus maximizing O2 saturation of the venous …
The application of bicarbonate recovers the chemical-physical properties of airway surface liquid in cystic fibrosis epithelia models
L Ferrera, V Capurro, L Delpiano, A Gianotti, O Moran - Biology, 2021 - mdpi.com
Simple Summary Cystic fibrosis (CF) is a multi-organ disease that affects the epithelia and
exocrine glands, particularly the lungs, but also the pancreas, liver, kidneys, and intestines …
exocrine glands, particularly the lungs, but also the pancreas, liver, kidneys, and intestines …
Pharmacological analysis of CFTR variants of cystic fibrosis using stem cell-derived organoids
Highlights•Analyzing CFTR mutations in patients with cystic fibrosis (CF).•Predicting drug
response for CF patients via organoid assays.•Modulating mutant CFTR activity with CF …
response for CF patients via organoid assays.•Modulating mutant CFTR activity with CF …